Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Rawat becomes president, CBO at Fusion

Plus: Sporos, Ajax, Nanocan and NeuroSense

September 29, 2021 11:02 PM UTC

Mohit Rawat became president and CBO at Fusion Pharmaceuticals Inc. (NASDAQ:FUSN). Rawat joins the radiopharmaceuticals company from the oncology division of Novartis AG (SIX:NOVN; NYSE:NVS), where he was VP and global disease lead.

Cancer, fibrosis, inflammation and immune disease company Sporos Bioventures LLC hired Amit Rakhit as CEO. Rakhit comes from Ovid Therapeutics Inc. (NASDAQ:OVID), where he was president and CMO. He  previously held various senior roles at Biogen Inc. (NASDAQ:BIIB) and Bristol Myers Squibb Co. (NYSE:BMY)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article